Cozad Asset Management Inc Eli Lilly & CO Transaction History

Cozad Asset Management Inc

$1.02 Billion
Q3 2024

A detailed history of Cozad Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Cozad Asset Management Inc holds 18,066 shares of LLY stock, worth $14.7 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares

18,066

Previous 15,873 13.82%

Holding current value

$14.7 Million

Previous $14.4 Million 11.37%

% of portfolio

1.57%

Previous 1.44%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$772.14 - $960.02 $1.69 Million - $2.11 Million	2,193 Added 13.82%	18,066 $16 Million
Q2 2024 Aug 02, 2024	BUY	$724.87 - $909.04 $4.32 Million - $5.42 Million	5,960 Added 60.12%	15,873 $14.4 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $4.03 Million - $5.39 Million	6,804 Added 218.85%	9,913 $7.71 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $100,311 - $118,253	-191 Reduced 5.79%	3,109 $1.81 Million
Q2 2023 Jul 26, 2023	SELL	$350.74 - $468.98 $42,088 - $56,277	-120 Reduced 3.51%	3,300 $1.55 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $196,467 - $228,923	611 Added 21.75%	3,420 $1.25 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $5,929 - $6,757	-20 Reduced 0.71%	2,809 $908,000
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $5,574 - $6,545	20 Added 0.71%	2,829 $917,000
Q1 2022 Apr 29, 2022	BUY	$234.69 - $291.66 $245,251 - $304,784	1,045 Added 59.24%	2,809 $804,000
Q4 2021 Feb 01, 2022	SELL	$224.85 - $279.04 $62,733 - $77,852	-279 Reduced 13.66%	1,764 $487,000
Q1 2021 Apr 29, 2021	BUY	$164.32 - $212.72 $39,436 - $51,052	240 Added 13.31%	2,043 $382,000
Q3 2020 Oct 28, 2020	BUY	$146.22 - $169.13 $17,546 - $20,295	120 Added 7.13%	1,803 $267,000
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $38,096 - $47,152	-320 Reduced 15.98%	1,683 $233,000
Q4 2019 Jan 16, 2020	SELL	$106.92 - $132.43 $12,295 - $15,229	-115 Reduced 5.43%	2,003 $263,000
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $30,435 - $33,105	-285 Reduced 11.86%	2,118 $237,000
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $9,971 - $11,638	-90 Reduced 3.61%	2,403 $266,000
Q4 2018 Jan 14, 2019	BUY	$105.9 - $118.64 $16,838 - $18,863	159 Added 6.81%	2,493 $288,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $200,397 - $250,461	2,334 New	2,334 $250,000

Others Institutions Holding LLY

# of Institutions

3,965

Shares Held

751M

Call Options Held

6.32M

Put Options Held

8.66M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $771B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cozad Asset Management Inc with notifications on news.

Account

Cozad Asset Management Inc Eli Lilly & CO Transaction History